In the specific setting of CCA, from their first identification, FGFR2 gene fusions have been suggested to represent a unique clinical and molecular subtype of iCCA, that has been reported in approximately one fifth of all iCCAs [52,53]. Here, FGFR2 is linked to cholangiocarcinoma.